North America Smart Pills Market to 2028 - By Size, Share, Growth by End User and Forecast| Business Market Insights

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. North America Smart Pills Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. North America Smart Pills Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Rising Demand for Minimally Invasive Surgical Procedures Favors the Market Growth

5.2 Market Opportunities

5.2.1 Increasing Demand for Drug Delivery System Creates Significant Opportunities in the Market

5.3 Future Trends

5.3.1 Remote Patient Monitoring Through Smart Pills

5.4 Impact of Drivers and Restraints

6. North America Smart Pills Market Regional Analysis

6.1 North America Smart Pills Market Overview

6.2 North America Smart Pills Market Revenue 2019-2028 (US$ Million)

6.3 North America Smart Pills Market Forecast Analysis

7. North America Smart Pills Market Analysis – by Application

7.1 Capsule Endoscopy

7.1.1 Overview
7.1.2 Capsule Endoscopy: North America Smart Pills Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Drug Delivery

7.2.1 Overview
7.2.2 Drug Delivery: North America Smart Pills Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Patient Monitoring

7.3.1 Overview
7.3.2 Patient Monitoring: North America Smart Pills Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Smart Pills Market Analysis – by Disease Indication

8.1 Gastrointestinal Diseases

8.1.1 Overview
8.1.2 Gastrointestinal Diseases: North America Smart Pills Market – Revenue and Forecast to 2028 (US$ Million)

8.2 Neurological Disorders

8.2.1 Overview
8.2.2 Neurological Disorders: North America Smart Pills Market – Revenue and Forecast to 2028 (US$ Million)

8.3 Cancer

8.3.1 Overview
8.3.2 Cancer: North America Smart Pills Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Inherited Disorders

8.4.1 Overview
8.4.2 Inherited Disorders: North America Smart Pills Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Other Disease Indications

8.5.1 Overview
8.5.2 Other Disease Indications: North America Smart Pills Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Smart Pills Market Analysis – by End User

9.1 Hospitals and Clinics

9.1.1 Overview
9.1.2 Other Disease Indications: North America Smart Pills Market – Revenue and Forecast to 2028 (US$ Million)

9.2 Research Institutes

9.2.1 Overview
9.2.2 Other Disease Indications: North America Smart Pills Market – Revenue and Forecast to 2028 (US$ Million)

9.3 Home Healthcare

9.3.1 Overview
9.3.2 Other Disease Indications: North America Smart Pills Market – Revenue and Forecast to 2028 (US$ Million)

10. North America Smart Pills Market – North America Analysis

10.1 North America

10.1.1 North America Smart Pills Market Breakdown, by Key Country, 2022 and 2028 (%)
10.1.1.1 North America Smart Pills Market – Revenue and Forecast Analysis – by Country
10.1.1.1 US: North America Smart Pills Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 US: North America Smart Pills Market Breakdown, by Application
10.1.1.1.2 US: North America Smart Pills Market Breakdown, by Disease Indication
10.1.1.1.3 US: North America Smart Pills Market Breakdown, by End User

10.1.1.2 Canada: North America Smart Pills Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Canada: North America Smart Pills Market Breakdown, by Application
10.1.1.2.2 Canada: North America Smart Pills Market Breakdown, by Disease Indication
10.1.1.2.3 Canada: North America Smart Pills Market Breakdown, by End User

10.1.1.3 Mexico : North America Smart Pills Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 Mexico : North America Smart Pills Market Breakdown, by Application
10.1.1.3.2 Mexico : North America Smart Pills Market Breakdown, by Disease Indication
10.1.1.3.3 Mexico : North America Smart Pills Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. North America Smart Pills Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Capso Vision, Inc.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Medtronic

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Check-Cap

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 PENTAX Medical

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Olympus Corporation

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Otsuka Holdings Co., Ltd.

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

14. Appendix

14.1 About Business Market Insights